Rosen, a leading national firm, encourages renovaro biosciences inc. investors to inquire about securities class action investigation – renb

New york--(business wire)--why: rosen law firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of renovaro biosciences inc. (nasdaq: renb) resulting from allegations that renovaro may have issued materially misleading business information to the investing public. so what: if you purchased renovaro securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arra.
RENB Ratings Summary
RENB Quant Ranking